• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Genetic Test Spots Patients at Risk From Viral Infections

Theresa42

Well-known member
Hat-tips Carol@SC & SusanC!

Genetic Test Spots Patients at Risk From Viral Infections
Aug 19, 2007

A genetic method of identifying patients most likely to develop life-threatening complications from SARS, bird flu and other dangerous viral infections has been discovered by Canadian researchers.

They analyzed blood samples from 40 people infected with SARS (severe acute respiratory syndrome) during the 2003 outbreak in Toronto. They found that patients with one kind of interferon gene-expression pattern recovered quickly, while those with another pattern became seriously ill or died, the Toronto Star reported.

Interferons -- proteins produced by white blood cells -- are the body's first-line defense against viruses. SARS patients with abnormal interferon patterns didn't produce enough antibodies to fight the virus, the study found. It was published Thursday in the Journal of Virology.

The findings provide new insight into how the immune system responds to SARS and could help doctors identify which patients with severe viral infections require specialized treatments, the Star reported.

http://www.healthday.com/Article.asp?AID=607471

Cameron et al, Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome
Journal of Virology, August 2007, p. 8692-8706, Vol. 81, No. 16

http://jvi.asm.org/cgi/content/abstract/81/16/8692
 
Back
Top